MeiraGTx Holdings (MGTX) EBT Margin Growth (3y) (2022 - 2025)

MeiraGTx Holdings (MGTX) EBT Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -484.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 132.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -674,462.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8,006.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 71,157.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -5,319.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,980.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 31,363.00
10 MeiraGTx Holdings 1.10 Bn 1.03 Bn - -80,090.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -77,419.00
Sep 30, 2025 -1.14 Mn
Jun 30, 2025 -88,909.00
Dec 31, 2024 -11,819.00
Sep 30, 2024 -3,850.00
Jun 30, 2024 -1.77 Mn
Mar 31, 2024 -651,602.00
Dec 31, 2023 66,487.00
Sep 30, 2023 -57,171.00
Jun 30, 2023 13,800.00
Mar 31, 2023 -25,938.00
Dec 31, 2022 86,630.00
Sep 30, 2022 -20,545.00
Jun 30, 2022 82,223.00
Mar 31, 2022 212,995.00